Chemoinformaics analysis of (+)-Isodihydrocarvone
Molecular Weight | 152.237 | nRot | 1 |
Heavy Atom Molecular Weight | 136.109 | nRig | 8 |
Exact Molecular Weight | 152.12 | nRing | 1 |
Solubility: LogS | -2.151 | nHRing | 0 |
Solubility: LogP | 2.222 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 0 | BPOL | 16.9193 |
QED | 0.528 |
Synth | 3.423 |
Natural Product Likeliness | 2.118 |
NR-PPAR-gamma | 0.011 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.384 |
MDCK | 0.0000246 |
BBB | 0.984 |
PPB | 0.539705 |
VDSS | 1.038 |
FU | 0.401954 |
CYP1A2-inh | 0.121 |
CYP1A2-sub | 0.762 |
CYP2c19-inh | 0.047 |
CYP2c19-sub | 0.851 |
CYP2c9-inh | 0.025 |
CYP2c9-sub | 0.569 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.896 |
CYP3a4-inh | 0.033 |
CYP3a4-sub | 0.321 |
CL | 13.904 |
T12 | 0.723 |
hERG | 0.013 |
Ames | 0.037 |
ROA | 0.052 |
SkinSen | 0.084 |
Carcinogencity | 0.77 |
EI | 0.891 |
Respiratory | 0.463 |
NR-Aromatase | 0.01 |
Antiviral | No |
Prediction | 0.90833 |